Kinetics of Recombinant Adenovirus Type 5, Vaccinia Virus, Modified Vaccinia Ankara Virus, and DNA Antigen Expression In Vivo and the Induction of Memory T-Lymphocyte Responses
Open Access
- 1 April 2008
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 15 (4) , 691-696
- https://doi.org/10.1128/cvi.00418-07
Abstract
While a new generation of vaccine vectors has been developed for eliciting cellular immune responses, little is known about the optimal routes for their administration or about the ramifications of the kinetics of in vivo vaccine antigen expression for immunogenicity. We evaluated the kinetics of vaccine antigen expression by real-time in vivo photon imaging and showed dramatic differences in these kinetics using different vectors and different routes of administration. Further, using a gamma interferon enzyme-linked immunospot assay to measure T-lymphocyte immune responses, we observed an association between the kinetics of vaccine antigen expression in vivo and the magnitude of vaccine-elicited memory T-lymphocyte responses. These results highlight the utility of the real-time in vivo photon-imaging technology in evaluating novel immunization strategies and suggest an association between the kinetics of vaccine antigen clearance and the magnitude of vaccine-elicited T-lymphocyte memory immune responses.Keywords
This publication has 28 references indexed in Scilit:
- Chemical adjuvants for plasmid DNA vaccinesVaccine, 2007
- Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell inductionJournal of General Virology, 2007
- High-Potency Human Immunodeficiency Virus Vaccination Leads to Delayed and Reduced CD8 + T-Cell Expansion but Improved Virus ControlJournal of Virology, 2005
- β–Amino Ester Polymers Facilitate in Vivo DNA Transfection and Adjuvant Plasmid DNA ImmunizationMolecular Therapy, 2005
- Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy developmentGene Therapy, 2004
- Luciferase Imaging of a Neurotropic Viral Infection in Intact AnimalsJournal of Virology, 2003
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Ethical Decision Making About Animal ExperimentsEthics & Behavior, 1997
- Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with γ‐interferonImmunology & Cell Biology, 1990
- Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) DiseaseNew England Journal of Medicine, 1987